Etilevodopa hydrochloride

Modify Date: 2024-01-09 10:45:14

Etilevodopa hydrochloride Structure
Etilevodopa hydrochloride structure
Common Name Etilevodopa hydrochloride
CAS Number 39740-30-2 Molecular Weight 261.70200
Density N/A Boiling Point N/A
Molecular Formula C11H16ClNO4 Melting Point N/A
MSDS N/A Flash Point N/A

 Use of Etilevodopa hydrochloride


Etilevodopa (L-Dopa ethyl ester) hydrochloride, an ethyl-ester prodrug of Levodopa, is rapidly hydrolyzed to Levodopa and ethanol by nonspecific esterases in the gastrointestinal tract. Etilevodopa hydrochloride is used for the treatment of Parkinson disease (PD). Levodopa is the direct precursor of dopamine and is a suitable prodrug as it facilitates CNS penetration and delivers dopamine[1][2][3].

 Names

Name (S)-3,4-dihydroxyphenylalanine ethyl ester hydrochloride
Synonym More Synonyms

 Etilevodopa hydrochloride Biological Activity

Description Etilevodopa (L-Dopa ethyl ester) hydrochloride, an ethyl-ester prodrug of Levodopa, is rapidly hydrolyzed to Levodopa and ethanol by nonspecific esterases in the gastrointestinal tract. Etilevodopa hydrochloride is used for the treatment of Parkinson disease (PD). Levodopa is the direct precursor of dopamine and is a suitable prodrug as it facilitates CNS penetration and delivers dopamine[1][2][3].
Related Catalog
In Vitro Etilevodopa (L-Dopa ethyl ester) hydrochloride passes unchanged through the stomach to the duodenum, where it is rapidly hydrolyzed by local esterases to Levodopa and ethanol, and is subsequently absorbed into the blood stream as Levodopa[1]. Compared with standard Levodopa, Etilevodopa hydrochloride has greater solubility in the stomach, faster passage to the small intestine, and a shortened time to maximum Levodopa concentration[2].
References

[1]. Djaldetti R, et al. Pharmacokinetics of etilevodopa compared to levodopa in patients with Parkinson's disease: an open-label, randomized, crossover study. Clin Neuropharmacol. 2003 Nov-Dec;26(6):322-6.

[2]. Blindauer K, et al. A randomized controlled trial of etilevodopa in patients with Parkinson disease who have motor fluctuations. Arch Neurol. 2006 Feb;63(2):210-6.

[3]. Haddad F, et al. Dopamine and Levodopa Prodrugs for the Treatment of Parkinson's Disease. Molecules. 2017 Dec 25;23(1). pii: E40.

 Chemical & Physical Properties

Molecular Formula C11H16ClNO4
Molecular Weight 261.70200
Exact Mass 261.07700
PSA 92.78000
LogP 2.03300

 Synonyms

L-DOPA Ethyl Ester Hydrochloride
Top Suppliers:I want be here




Get all suppliers and price by the below link:

Etilevodopa hydrochloride suppliers


Price: ¥4400/10 mM * 1  mL in Water

Reference only. check more Etilevodopa hydrochloride price